Century Therapeutics, Inc.
IPSC
$0.537
$0.0173.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.40% | -0.72% | -3.47% | -7.05% | -4.38% |
| Total Depreciation and Amortization | 1.99% | 9.80% | 15.62% | 31.15% | 54.55% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -86.38% | -68.56% |
| Total Other Non-Cash Items | -51.93% | 4.31% | 19.31% | 106.25% | 109.81% |
| Change in Net Operating Assets | -198.91% | -187.76% | -69.95% | 971.11% | -92.43% |
| Cash from Operations | -24.66% | -31.89% | -1.93% | 12.31% | -728.72% |
| Capital Expenditure | 98.88% | 94.85% | 80.25% | 70.55% | 55.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.54% | -19.61% | -81.58% | -46.02% | 328.40% |
| Cash from Investing | -22.33% | -7.26% | -99.12% | -33.60% | 565.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | 8,519.84% | 7,673.01% | -4.23% | 8.52% | -96.79% |
| Repurchase of Common Stock | -69.10% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 866.71% | 906.65% | 893.01% | 1,001.92% | -135.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 132.24% | 96.69% | 54.24% | -2.76% | -231.55% |